Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-81.23%
↓ 264% below average
Average (3y)
-22.32%
Historical baseline
Range
High:-0.26%
Low:-81.23%
CAGR
+199.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -81.23% | -30853.1% |
| 2023 | -0.26% | +94.5% |
| 2022 | -4.76% | -57.3% |
| 2021 | -3.03% | - |